MT-8554

DRUG4 trials

Sponsors

Tanabe Pharma Corporation, Tanabe Pharma America, Inc.

Conditions

HealthyPainful Diabetic Peripheral NeuropathyVasomotor Symptoms (VMS)

Phase 1

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-8554 in Healthy Subjects

CompletedNCT02429102

Tanabe Pharma CorporationHealthy

Start: 2015-04-30End: 2015-11-30Updated: 2025-12-22

A Study to Investigate the Effect of MT-8554 on the Pharmacokinetics of Simvastatin and Rosuvastatin in Healthy Subjects

CompletedNCT02675309

Tanabe Pharma CorporationHealthy

Start: 2016-02-29End: 2016-03-31Updated: 2025-12-22

Phase 2

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

CompletedNCT03541200

Tanabe Pharma America, Inc.Vasomotor Symptoms (VMS)

Start: 2018-04-18End: 2019-11-15Updated: 2026-01-23

Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy

CompletedNCT05123196

Tanabe Pharma CorporationPainful Diabetic Peripheral Neuropathy

Start: 2021-11-16End: 2022-11-08Updated: 2025-12-22